SCHEMBL1312972

SCHEMBL1312972

C[C@@](F)(C(=O)Nc1ccccc1)N([N+](=O)[O-])[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 7/20 0.54
PDK2 Q15119 7/20 0.54
PDK3 Q15120 7/20 0.54
PDK4 Q16654 7/20 0.54
ABCC9 O60706 5/20 0.45
ABCC8 Q09428 5/20 0.45
KCNJ11 Q14654 5/20 0.45
KCNJ8 Q15842 5/20 0.45
CYP3A4 P08684 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16212234 0.75 PDK1 (0.70) PDK1PDK2PDK3PDK4ABCC9
SCHEMBL11875203 0.74 PDK1 (0.51) PDK1PDK2PDK3PDK4ABCC9
SCHEMBL5705066 0.73 MAPT (0.51) PDK1PDK2PDK3PDK4CYP3A4
SCHEMBL3129785 0.73 PDK1 (0.67) PDK1PDK2PDK3PDK4ABCC9
SCHEMBL9709058 0.72 PDK1 (0.71) PDK1PDK2PDK3PDK4ABCC9
SCHEMBL17223837 0.71 PDK1 (0.47) PDK1PDK2PDK3PDK4MEN1
SCHEMBL14849461 0.70 PDK1 (0.63) PDK1PDK2PDK3PDK4MEN1
SCHEMBL83110 0.70 L3MBTL1 (0.78) PDK1PDK2PDK3PDK4MEN1
SCHEMBL474941 0.70 HDAC1 (0.65) PDK1PDK2PDK3PDK4MEN1
SCHEMBL6359557 0.70 PDK1 (1.00) PDK1PDK2PDK3PDK4ABCC9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20120149743-A9 Selenophene and Selenazole Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC (US) 2012-06-14 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110275683-A1 Selenophene and Selenazole Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC (US) 2011-11-10 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
EP-2297167-A1 SELENOPHENE AND SELENAZOLE CARBOXYLIC ACID DERIVATIVES Ironwood Pharmaceuticals, Inc. (US) 2011-03-23 EP disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
WO-2010005528-A2 PYRROLOPYRIDINE CARBOXYLIC ACID DERIVATIVES IRONWOOD PHARMACEUTICALS INCORPORATED (US) 2010-01-14 WO disclosed
WO-2009148564-A1 SELENOPHENE AND SELENAZOLE CARBOXYLIC ACID DERIVATIVES IRONWOOD PHARMACEUTICALS INCORPORATED (US) 2009-12-10 WO disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed
EP-2049520-A2 INDOLE COMPOUNDS Ironwood Pharmaceuticals, Inc. (US) 2009-04-22 EP disclosed
WO-2008157740-A2 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2008-12-24 WO disclosed
WO-2008019357-A2 INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275683-A1 Selenophene and Selenazole Carboxylic Acid Derivatives DAO, DDO, SELENOI PDK1 734/4885PDK2 296/4885PDK3 358/4885
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PDK1 2158/4885PDK2 734/4885PDK3 543/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT PDK1 3391/4885PDK2 1733/4885PDK3 1799/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 PDK1 2999/4885PDK2 1776/4885PDK3 1339/4885
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives SDHA, ALDH5A1, SDHB PDK1 6/4885PDK2 19/4885PDK3 64/4885
US-20120149743-A9 Selenophene and Selenazole Carboxylic Acid Derivatives DAO, DDO, SELENOI PDK1 734/4885PDK2 296/4885PDK3 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.